Hernandez, M.; Cullell, N.; Cendros, M.; Serra-Llovich, A.; Arranz, M.J.
Clinical Utility and Implementation of Pharmacogenomics for the Personalisation of Antipsychotic Treatments. Pharmaceutics 2024, 16, 244.
https://doi.org/10.3390/pharmaceutics16020244
AMA Style
Hernandez M, Cullell N, Cendros M, Serra-Llovich A, Arranz MJ.
Clinical Utility and Implementation of Pharmacogenomics for the Personalisation of Antipsychotic Treatments. Pharmaceutics. 2024; 16(2):244.
https://doi.org/10.3390/pharmaceutics16020244
Chicago/Turabian Style
Hernandez, Marta, Natalia Cullell, Marc Cendros, Alexandre Serra-Llovich, and Maria J. Arranz.
2024. "Clinical Utility and Implementation of Pharmacogenomics for the Personalisation of Antipsychotic Treatments" Pharmaceutics 16, no. 2: 244.
https://doi.org/10.3390/pharmaceutics16020244
APA Style
Hernandez, M., Cullell, N., Cendros, M., Serra-Llovich, A., & Arranz, M. J.
(2024). Clinical Utility and Implementation of Pharmacogenomics for the Personalisation of Antipsychotic Treatments. Pharmaceutics, 16(2), 244.
https://doi.org/10.3390/pharmaceutics16020244